Le cluster Octreotide (analogs & derivatives) - Octreotide (diagnostic use)
| 000172 (1999) | Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. | |
| 000224 (1994) | Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison. | |
| 000206 (1996) | Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours. | |
| 000207 (1996) | Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. | |
| 000186 (1997) | Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. | |
| 000197 (1996) | Somatostatin receptor imaging in small cell lung cancer. | |
| 000199 (1996) | Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. | |
| 000221 (1995) | Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. | |
| 000140 (2002) | Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy. | |
| 000193 (1997) | Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. | |
| 000227 (1994) | Scintiscans and carcinoid tumors. | |
| 000114 (2005) | Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas. | |
| 000125 (2004) | Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans. | |
| 000136 (2002) | Parathyroid adenoma visualization on octreotide scintigraphy. | |
| 000228 (1994) | Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate. | |
| 000039 (2011) | Contribution of SPECT/CT 111In-DTPA cisternography in the localization of an intermittent cerebrospinal fluid leak in a 3-year-old girl with congenital bone defect. | |
| 000046 (2010) | [Somatostatin receptor-based imaging and therapy of digestive endocrine tumors]. | |
| 000060 (2009) | Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. | |
| 000075 (2008) | Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy. | |
| 000087 (2007) | In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer. | |
| 000139 (2002) | Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft. | |
| 000142 (2001) | Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. | |
| 000144 (2001) | Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. | |
| 000147 (2001) | Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases. | |
| 000149 (2001) | Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy. | |
| 000154 (2000) | Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography. | |
| 000158 (2000) | 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis. | |
| 000161 (1999) | Subarachnoid-pleural fistula complicating thoracoscopy: value of In-111 DTPA myeloscintigraphy. | |
| 000162 (1999) | Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy. | |
| 000174 (1999) | 111Indium antimyosin antibody imaging of primary myocardial involvement in systemic diseases. | |
| 000175 (1998) | Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. | |
| 000176 (1998) | Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. | |
| 000185 (1997) | Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. | |
| 000191 (1997) | False-positive somatostatin receptor scintigraphy due to an accessory spleen. | |
| 000192 (1997) | Effects of preoperative intentional hemodilution on the extravasation rate of albumin and fluid. | |
| 000195 (1996) | Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor. | |
| 000198 (1996) | Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody. | |
| 000212 (1995) | Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer? | |
| 000214 (1995) | Per operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probe. | |
| 000219 (1995) | Effects of smoking on bronchial clearance of technetium-99m-DTPA and indium-113m-DTPA. | |
| 000220 (1995) | Complementary approach for the determination of histidine in the metal-binding site of an anti-DTPA-indium monoclonal antibody. | |
| 000226 (1994) | Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. | |
| 000229 (1994) | Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients. | |
| 000243 (1993) | New application of myocardial antimyosin scintigraphy: diagnosis of myocardial disease in polymyositis. | |
| 000248 (1993) | Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. | |
| 000269 (1991) | Imaging of myocardial infarction in dogs and humans using monoclonal antibodies specific for human myosin heavy chains. | |
| 000275 (1990) | Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. | |
| 000276 (1990) | Scintigraphic assessment of indium-111-labeled granulocyte splenic pooling: a new approach to inflammatory bowel disease activity. | |
| 000279 (1990) | Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments. | |
| 000280 (1990) | Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA. | |
| 000281 (1990) | In vitro binding to granulocytes of two anti-NCA 95 monoclonal antibodies: Mab1 (ORIS) and Mabgc (Mallinckrodt). | |
| 000282 (1990) | Imaging of inflammatory bowel disease (IBD) and scintigraphic assessment of resected colon: comparison of 111 In-oxine and 99mTC HMPAO leucocyte labelling. | |
| 000297 (1988) | Pulmonary clearance of three aerosolized solutes in oleic acid-induced lung injury. | |
| 000313 (????) | Indium-111 labeling of low density lipoproteins with the DTPA-bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization. |
| This area was generated with Dilib version V0.5.76. |  |